Cart

Your Cart is Empty

Back To Shop
Sale!

Adaptimmune Therapeutics Plc

$10.00

Adaptimmune (AI) is a clinical-stage biopharmaceutical firm. It focuses on providing novel cell therapies using its proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell, to patients who are suffering from solid tumors.

“Adaptimmune Therapeutics Plc Analysis ” solution has 1000 words and comprises – 

  • Overview
  • PESTEL Analysis
  • Political Factors
  • Economic Factors
  • Social Factors
  • Technological Factors
  • Environmental Factors
  • Legal Factors
Sale!

Adaptimmune (AI) is a clinical-stage biopharmaceutical firm. It focuses on providing novel cell therapies using its proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell, to patients who are suffering from solid tumors.

“Adaptimmune Therapeutics Plc Analysis ” solution has 1000 words and comprises – 

  • Overview
  • PESTEL Analysis
  • Political Factors
  • Economic Factors
  • Social Factors
  • Technological Factors
  • Environmental Factors
  • Legal Factors

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Cart

Your Cart is Empty

Back To Shop